Effects of partially hydrolyzed whey infant formula on the risk of developing atopic dermatitis in infants

Tuesday, Oct 30, 2018

This review paper summarized results from eight clinical trials and confirmed that partially hydrolyzed whey-based formula supports normal growth, and potentially reduces the risk of atopic dermatitis in non-exclusively breastfed infants from the general population during the first four to six months of life.

Reference:

Sauswer J, et al. Partially hydrolyzed whey infant formula: Literature review on effects and the risk of developing atopic dermatitis in infants from the general population. Int Arch Allergy Immunol. 2018;177(2):123-134.
 

Other article that you might be interested in:

Human milk and allergic diseases

Link to Publication: www.ncbi.nlm.nih.gov/pubmed/30001534


WYE-EM-353-SEP-18

Latest Articles

Academic Activities

Scientific symposium – Critical connectivity: Assessing and supporting the development of brain and behaviour

Chairperson:

  • Dr Henry Au Yeung Cheuk-lun (Hong Kong)
Speakers:
  • Professor Weili Lin (USA)
  • Dr Daniel Chiu Cheung-shing (Hong Kong)
  • Dr Fanny Lam Wai-fan (Hong Kong)

The 28th International Congress of Pediatrics (IPA) (NEW!)

17-22 August 2016, Vancouver, Canada

Science Updates

Oral immunotherapy using partially hydrolyzed formula for cow’s milk protein allergy (NEW!)

This randomized controlled trial found that oral immunotherapy with hydrolyzed cow’s milk protein-based formula (pHF) may safely enhance tolerance to cow’s milk in children with cow’s milk allergy (CMPA), suggesting it may be a potential therapeutic strategy for this group.

Resources

Picky Eating eBook

Practical tips to overcome picky eating behaviours by Kate Di Prima, an accredited practicing dietitian specializing in Paediatrics and a spokesperson for the Dietitians Association of Australia. 

Growth Charts

The WHO Child Growth Standards were developed using data collected in the WHO Multicentre Growth Reference Study (MGRS)1.